about
A Naturally Selected Dimorphism within the HLA-B44 Supertype Alters Class I Structure, Peptide Repertoire, and T Cell RecognitionThermodynamic and structural analysis of peptide- and allele-dependent properties of two HLA-B27 subtypes exhibiting differential disease associationDual, HLA-B27 Subtype-dependent Conformation of a Self-peptideStructural Basis for T Cell Alloreactivity among Three HLA-B14 and HLA-B27 AntigensLoss of recognition by cross-reactive T cells and its relation to a C-terminus-induced conformational reorientation of an HLA-B*2705-bound peptideTwo HLA-B14 subtypes (B*1402 and B*1403) differentially associated with ankylosing spondylitis differ substantially in peptide specificity but have limited peptide and T-cell epitope sharing with HLA-B27.The synovio-entheseal complex in enthesoarthritis.Spondyloarthritis: Matrix Metalloproteinasesas Biomarkers of Pathogenesis and Response to Tumor Necrosis Factor (TNF) Inhibitors.Pathogenicity of Misfolded and Dimeric HLA-B27 MoleculesUpdate in spondylarthropathy.MHC-bound antigens and proteomics for novel target discovery.A computational docking study on the pH dependence of peptide binding to HLA-B27 sub-types differentially associated with ankylosing spondylitis.When is arthritis reactive?Peptides: the cornerstone of HLA-B27 biology and pathogenetic role in spondyloarthritis.Polymorphisms in the F Pocket of HLA-B27 Subtypes Strongly Affect Assembly, Chaperone Interactions, and Heavy-Chain Misfolding.HLA-B27 Anterior Uveitis: Immunology and Immunopathology.Induction of HLA-B27 heavy chain homodimer formation after activation in dendritic cellsThe amino acid at position 97 is involved in folding and surface expression of HLA-B27.Conformational dimorphism of self-peptides and molecular mimicry in a disease-associated HLA-B27 subtype.Allele-dependent similarity between viral and self-peptide presentation by HLA-B27 subtypes.HLA-B27: a registry of constitutive peptide ligands.Formation of HLA-B27 homodimers and their relationship to assembly kinetics.Preliminary X-ray diffraction analysis of crystals from the recombinantly expressed human major histocompatibility antigen HLA-B*2704 in complex with a viral peptide and with a self-peptide.Natural MHC class I polymorphism controls the pathway of peptide dissociation from HLA-B27 complexesX-ray diffraction analysis of crystals from the human major histocompatibility antigen HLA-B*2706 in complex with a viral peptide and with a self-peptide.HLA-B27 subtype oligomerization and intracellular accumulation patterns correlate with predisposition to spondyloarthritis.Purification, crystallization and preliminary X-ray diffraction analysis of the human major histocompatibility antigen HLA-B*2703 complexed with a viral peptide and with a self-peptide.Expression, purification and preliminary X-ray crystallographic analysis of the human major histocompatibility antigen HLA-B*1402 in complex with a viral peptide and with a self-peptideDominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA.An evaluation of Com-B27, a fluorescein-conjugated mouse anti-HLA-B27 reagent.Novel HLA B*2714 and B*2708 allele associations in seronegative spondarthritis patients and haemophilia patients with chronic synovitis in India.Differential peptide dynamics is linked to major histocompatibility complex polymorphism.A simple and practical agglutination assay for human leucocyte antigen-B27 typing.Diversity of human leukocyte antigen-B27 alleles in Han population of Hunan province, southern China.Serum sCTLA-4 levels and clinical manifestations in ankylosing spondylitis patients
P2860
Q27641906-2AC6DE9D-95B6-4334-8D21-03F70F4B757AQ27642338-5937BE3C-F00B-4AFF-9A1C-FC077900DD1DQ27642989-102AE038-1751-4AEE-AD02-26BA4ABFCB1EQ27646543-386B509B-8556-4D88-BE3E-11FB28F9312CQ27666781-E67A1585-5853-4267-860C-8402CEA98E9BQ33222105-2C7613C1-6F43-464A-9C32-3954902BD62DQ33360030-D58AF133-8899-4D51-9CDB-E3B274D9E302Q33624763-2B5140D2-C3C7-44F8-B5CE-73747EA2E31AQ34921584-0364BA94-1E7F-4788-B7CD-27B135ABF9C9Q35661558-E3B3FBB2-DCDF-4D99-9799-207A1F5F8CB8Q35911151-E248AF83-347F-43F3-BBB2-E2FCE5BEB092Q36099514-5D14F7E6-FA99-4F2C-8EAC-CB2150D52001Q36528238-CCA21877-7E48-427B-8A19-EB82DB8F60ACQ37167616-C855FD3B-D657-465F-93E7-4DFA0A08AF8FQ38741792-3CF83428-C892-4FD5-930C-79224E46BF08Q38849274-1B97766D-CDA0-4304-9E3D-DDF881D6297EQ39945166-B62D86D5-A009-417F-840A-ADFBE91028FFQ40339075-00007B6B-B643-43CC-8DA6-44932B1F8EE1Q40362650-68EA9BDC-DCAB-4F6D-8FB6-144AF856F862Q40493543-7EDEB5CF-CD86-488E-ACD8-803BFE3D6661Q40563603-5807E230-1348-4741-9BAF-E7A9D6D7141EQ40605908-3703DCD8-C70A-40E7-8565-51AB769D7D48Q41542768-3641AFD8-E4BD-4D16-BFA2-CA520C7D3AD9Q41678328-6A6ABA53-B6B2-4F03-8B12-9E1CE77DD69EQ42001737-F9785967-2BE0-4725-B0EE-4C10C82E7E7CQ42221004-A0F8FBC9-2072-4E1E-92DD-C32F295E7036Q42411694-3AF11B53-F36C-4362-9AC2-C6087EB9F664Q42625853-4FA8000A-B8AF-4E66-8C1D-FB05CD2EF2ACQ44291572-03E63617-AD9C-4007-8150-A5A2FCD38BD7Q44550042-A7A64947-50F6-43C4-9957-242C1698CF6AQ45864194-76A54856-93BD-456F-80DE-277A49395EBCQ47763816-E2E60D41-2C0D-4C51-90EE-C620F06DD9CDQ52932468-316EAE88-6A98-4D08-9605-EFA0A774C04CQ54590666-9A0C6025-32C5-4468-B678-0DAF81F71A8FQ56891375-C96FEDAD-B80E-47AB-A9AB-5DB9DA49B844
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
HLA-B27 and the pathogenesis of spondyloarthritis.
@ast
HLA-B27 and the pathogenesis of spondyloarthritis.
@en
type
label
HLA-B27 and the pathogenesis of spondyloarthritis.
@ast
HLA-B27 and the pathogenesis of spondyloarthritis.
@en
prefLabel
HLA-B27 and the pathogenesis of spondyloarthritis.
@ast
HLA-B27 and the pathogenesis of spondyloarthritis.
@en
P2860
P1433
P1476
HLA-B27 and the pathogenesis of spondyloarthritis.
@en
P2093
López de Castro JA
P2860
P304
P356
10.1034/J.1399-0039.2002.600301.X
P577
2002-09-01T00:00:00Z